Sushma Ramsinghani

Sushma Ramsinghani Department Chair  Department of Pharmaceutical Sciences University of the Incarnate Word Texas USA

Biography :

Dr. Ramsinghani obtained her Bachelor in Pharmacy (B.Pharm) and Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry from India.  Thereafter, she worked as an analytical chemist in a pharmaceutical manufacturing company in India.  She went on to obtain her doctoral degree in Medicinal Chemistry from the University of Toledo, Toledo, Ohio, in 1998, and followed it with postdoctoral research experience at the University of Kentucky, Lexington, Kentucky.

Dr. Ramsinghani is a member of American Chemical Society (ACS), Sigma Xi (the Scientific Research Society), and American Association of Colleges of Pharmacy (AACP). 

Research Interest :

Her current research interest is in the area of post-translational modification of proteins by poly(ADP-ribosyl)ation and its implication in cancer therapy. She has published in peer-reviewed journals.  She has experience in chemical syntheses, protein chemistry and cell biology techniques. Dr. Ramsinghani is actively engaged in research and grant-writing. She was the principal investigator of an NIH funded subproject to develop chemo-potentiating agents to enhance the effects of cancer therapy. She was a co-investigator in an NIH funded sub-project to synthesize thio-ether conjugates of MDMA (Ecstasy) in an attempt to understand how MDMA mediates its neuronal toxicity.  She was also a co-investigator on a breast cancer research project.

 

Sushma Ramsinghani Assistant Dean and Chair Department of Pharmaceutical Sciences ramsingh@uiwtx.edu

links

https://www.linkedin.com/in/ramsinghani-sushma-0872a644

https://www.facebook.com/sushma.ramsinghani

• Worked at University of the Incarnate Word
• 

  Studied at University of Toledo

  Past: Arya Girls High School, Nairobi, Kenya
• 

  Lives in San Antonio, Texas

  From Bhopal, Madhya Pradesh

University of the Incarnate Word

One of the heading exhaustive colleges in Texas, the University of the Incarnate Word in San Antonio strives to teach men and ladies who will get to be concerned and illuminated subjects with qualities created in a Judeo-Christian convention. The school was confessed to participation in the Association of Colleges and Secondary Schools in 1919, and joined the Texas Association of Colleges as a senior school in 1920. The Graduate Studies division was built in 1950. Male understudies were initially conceded into the school's undergrad programs in 1970. Incarnate Word College turned into the University of the Incarnate Word in 1996. Today, UIW is a Hispanic-Serving Institution under government rules. UIW offers 80 undergrad and graduate fields of study, including the Ph.d. in Education and doctoral degrees in drug store (Pharm.d.), optometry (OD), nursing practice (DNP), active recuperation (DPT) and business organization (DBA). UIW is one of twenty colleges in the U.s. with an optometry program. UIW additionally made the national Top 10 Honor Roll in the medium-sized order for colleges with enlistments somewhere around 3,000 and 9,999 understudies. The graduate nursing project has been perceived as one of the main 65 graduate projects broadly by U.s. News Media Group. In 2012, UIW was positioned No. 21 broadly by Super Scholar for having one of the best online school programs in the U.s. Sushma Ramsinghani, Ph.D. . ASSISTANT DEAN, DEPARTMENT CHAIR AND PROFESSOR, PHARMACEUTICAL SCIENCES PHONE: (210) 883-1031 EMAIL: RAMSINGH@UIWTX.EDU Education: Bachelor of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore, India, 1984 Master of Pharmacy, Dr. H.S. Gaur Vishwavidyalaya, Saugar, India, 1986 Doctor of Philosophy, Medicinal Chemistry, University of Toledo, Ohio, 1998 Postdoctoral Training University of Kentucky (Lexington),  Breast Cancer Research, 1998-1999 Funded Grants Development of a non-cleavable analog of adenosine diphosphate (hydroxymethyl)pyrrolidinediol (ADP-HPD) as a therapeutic agent in cancer therapy (PI, subproject) funded by Extramural Associates Research Development Award-NIH Development of Inhibitors of Poly(ADP-ribose) glycohydrolase as Chemo-potentiating agents in Cancer Therapy (PI, subproject) under the Hampton University Health Disparities Reduction Project funded by National Center for Minority Health and Health Disparities (NCMDH) Synthesis of Potential Metabolites and Antagonists of MDMA (Co-I) under MIDARP at Hampton University funded by National Institute on Drug Abuse (NIDA) MBRS Equipment Grant (Co-I) Dr. Ramsinghani is a native of India where she obtained her Bachelor of Pharmacy (B.Pharm) and Master of Pharmacy (M.Pharm) degrees.  She worked as an analytical chemist in a pharmaceutical manufacturing company in India after completion of her master’s degree.  She went on to obtain her doctoral degree in Medicinal Chemistry from University of Toledo in Toledo, Ohio in 1998 and followed it with postdoctoral research experience at University of Kentucky, Lexington, Kentucky. Dr. Ramsinghani is a member of American Chemical Society (ACS), Sigma Xi (the Scientific Research Society), and American Association of Colleges of Pharmacy (AACP).  Her current research interest is in the area of post-translational modification of proteins by poly(ADP-ribosyl)ation and its implication in cancer therapy.  She has published in peer-reviewed journals.  She has experience in chemical syntheses, protein chemistry and cell biology techniques.  Dr. Ramsinghani joined the faculty at Feik School of Pharmacy in 2008. In 2009, Dr. Ramsinghani was appointed chair of Department of Pharmaceutical Sciences.  Her teaching responsibilities are in the area of Medicinal Chemistry within the Pharmacotherapeutics series. Dr. Ramsinghani’s previous appointment was at Hampton University School of Pharmacy, Virginia from 2001-2008. Dr. Ramsinghani is actively engaged in research and grant-writing.  She was the principal investigator of an NIH funded subproject to develop chemo-potentiating agents to enhance the effects of cancer therapy.  She was a co-investigator in an NIH funded sub-project to synthesize thio-ether conjugates of MDMA (Ecstasy) in an attempt to understand how MDMA mediates its neuronal toxicity.  She was also a co-investigator on a breast cancer research project.

//////